TP53 and hepatocellular carcinoma: Epidemiological studies have shown that chronic viral infections (such as HBV, HCV, and HIV) and metabolic disorders (such as metabolic syndrome) are associated with disruption of the MDM2-p53 axis in HCC (Cao et al., 2020[24]).